Follow the Sun Pharma Advanced Research Company Limited stock price and the full management transaction log of the company, a listed equity based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Sun Pharma Advanced Research Company Limited has published 13 insider filings. Market capitalisation: €66.9bn. The latest transaction was filed on 23 February 2023 (Pledge). Among the most active insiders: Raksha S Valia. The full history is free.
13
Insider Decl.
n/a
Thresholds
€69m
3 ops.
Buy Volume
n/a
2 ops.
Sell Volume
14Σ signal
Buys €69mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,856 of 29,062 companies
66.7
score / 100
Value
72
Quality
61
FCF yld-3.9%
Earn yld23%
EV/EBITDA4.5x
ROE277%
Gross mgn-31%
Net mgn·
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
33,707,865 shares@ ₹44.500.035% mcap100.0% of flowWarrantsSEBI:7bd64a2dda8a9ab710dda4b7cbcfec9000131d34
13 of 13 declarations
About Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited is a pharmaceutical research company focused on developing new drugs. It is part of the Sun Pharma group, one of the largest drug manufacturers in India.